Literature DB >> 30011953

Development of Conjugate Addition of Lithium Dialkylcuprates to Thiochromones: Synthesis of 2-Alkylthiochroman-4-ones and Additional Synthetic Applications.

Shekinah A Bass1, Dynasty M Parker2, Tania J Bellinger3, Aireal S Eaton4, Angelica S Dibble5, Kaata L Koroma6, Sylvia A Sekyi7, David A Pollard8, Fenghai Guo9,10.   

Abstract

Lithium dialkylcuprates undergo conjugate addition to thiochromones to afford 2-alkylthiochroman-4-ones in good yields. This approach provide an efficient and general synthetic approach to privileged sulfur-containing structural motifs and valuable precursors for many pharmaceuticals, starting from common substrates-thiochromones. Good yields of 2-alkyl-substituted thiochroman-4-ones are attained with lithium dialkylcuprates, lithium alkylcyanocuprates or substoichiometric amount of copper salts. The use of commercially available inexpensive alkyllithium reagents will expedite the synthesis of a large library of 2-alkyl substituted thiochroman-4-ones for additional synthetic applications.

Entities:  

Keywords:  2-alkylthiochroman-4-ones; conjugate addition; lithium dialkyl cuprates; thiochroman-4-ones; thiochromones

Mesh:

Substances:

Year:  2018        PMID: 30011953      PMCID: PMC6099951          DOI: 10.3390/molecules23071728

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Sulfur-containing heterocycles are widely present in many bioactive natural products as well as pharmaceutical active molecules [1,2,3,4]. The sulfur-containing heterocycles are an understudied area when comparing to the oxygen-containing counterparts. In recent years, the development of efficient synthetic approaches to sulfur-containing compounds has gained much attention due to their widespread applications in biology, food chemistry, material science, and medicinal chemistry [1,2,3,4,5,6,7,8,9,10,11]. Sulfur-containing heterocycles, such as thiochromanone, thioflavanone, thiochromone, thioflavone, and their derivatives (Scheme 1) have been reported to display rich biological activities. For example, thioflavonoids, which are the sulfur analogues of flavonoids [12,13,14,15,16,17,18], display many biological activities, such as antimicrobial, antioxidant, inhibiting nitric oxide production, and antifungal et al. [3,19,20,21,22,23,24,25,26,27] Thiochroman-4-ones have been reported to display antifungal activities. Some thiochroman-4-one derivatives have been studied and shown to display the cytotoxic effect on tumor cells in vitro [28]. Recently, the in vitro antileishmanial and cytotoxic activities of some thiochroman-4-one derivatives have also been reported [29]. Many thiochromanone derivatives have been known to be effective “bioreductive alkylating agents”, inhibiting Ehrlich ascites tumor growth [21]. Other thiochroman-4-ones have shown the ability to kill tumor cells by inducing tumor cell apoptosis [30]. Thiochromanones, i.e., thiochroman-4-ones and 2-alkylthiochroman-4-ones, have become valuable synthons and precursors in organic synthesis in recent years. They are key precursors for certain bioactive antiproliferative agents [31]. Known as an important class of heterocycles [3,4], they are vital precursors of bioactive thiochroman-4-one 1,1-dioxanes, as well as benzothiazepins [20,21,32,33,34,35,36,37,38].
Scheme 1

Structures of Thiochromanone, Thioflavone, Thiochromone, and Thioflavanones.

Although some synthetic approaches to thiochroman-4-ones, thioflavone, and thiochromones have been reported in literature [28,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55], research on efficient synthesis of 2-substituted thiochroman-4-ones is an underexplored area when compared to O-containing counterparts. Synthetic approaches to 2-substituted thiochroman-4-ones utilizing Friedel-Crafts acylation of thiopropanoic acid [56], hydrogenation of thiochromones [57,58,59], and intramolecular thio-Michael addition [60,61,62,63,64,65,66] have been reported. Recently, a rhodium-catalyzed alkyne hydroacylation/thio conjugate addition sequence in the synthesis of thiochroman-4-ones, including thioflavanones, has also been reported [67]. In another approach, Wang and coworkers reported an enantioselective Rh-catalyzed conjugate addition to thiochromones [68]. We also reported a rapid entry to thioflavanones via the conjugate addition of diarylcuprates to thiochromones recently [69]. While most of these approaches provided efficient approaches to thioflavanones (2-arylthiochroman-4-ones), they do not work particularly well in introducing the aliphatic groups to furnish the desired 2-alkylthiochroman-4-ones. For example, rhodium-catalyzed conjugate addition to thiochromones only works well with arylzinc reagents to introduce aryl groups to thiochromones and it is not compatible with alkylzinc reagents or aliphatic groups in general [68]. In an effort to develop a quick entry into 2-alkylthiochroman-4-ones by taking advantage of the readily available inexpensive alkyllithium reagents and copper salts, we now report the conjugate addition of lithium dialkylcuprates [70,71,72,73,74,75], prepared from the corresponding inexpensive commercially available alkyllithiums, to thiochromones 1 (see Supplementary Material for the preparation of these starting materials) to afford 2-alkylthiochroman-4-ones 2 in good yields (Figure 1).
Figure 1

Conjugate Addition of Lithium Dialkylcuprates to Thiochromones.

2. Results and Discussions

We began our study with n-BuLi, copper (I) salt and thiochromone to investigate the reaction condition. No 1,4-adduct 2-n-butylthiochroman-4-one 4Aa was formed with 0.3 equivalent of CuI or CuCN without any additive (Table 1, entries 1–2, 0%). Lithium cyanocuprate (i.e., n-BuCuCNLi) also fail to add to thiochromone with the recovery of unreacted thiochromone (Table 1, entry 3, 0%). Under similar reaction condition, more reactive Gilman reagents [76] (i.e., n-Bu2CuLi) afforded only a trace amount of 1,4-adduct 4Aa (Table 1, entry 4). These results indicated that thiochromone is very sluggish towards the addition of lithium organocopper reagents without other additives/activators.
Table 1

Optimization of 1,4-Conjugate Addition of Alkylcuprates to Thiochromone.

Entries cCopper (I) Salt/Reagents aAdditive% Yield b
1CuI (0.3 equiv)none0
2CuCN (0.3 equiv)none0
3n-BuCuCNLinone0
4n-Bu2CuLinonetrace
5CuI (0.3 equiv)TMSCl66
6CuCN (0.3 equiv)TMSCl62
7n-BuCuCNLiTMSCl70
8n-Bu2CuLiTMSCl86
9n-Bu2CuLiTMSI85
10n-Bu2CuLiTMSOTf82

a. Reagents were prepared by adding n-BuLi to CuCN or CuI. b. Yields are based on isolated products by flash column chromatography. c. Reactions were allowed to stir for 12 h and warm up to room temperature before workup.

Lewis acids, such as trimethylsilyl chloride (TMSCl), have been known to accelerate 1,4-conjugate additions of both stoichiometric organocuprates and catalytic amount of copper (I) salts [77,78,79,80,81,82,83,84]. In our investigation, we found out that the yield of desired 1,4-adduct 4Aa can be increased to 66% using 0.3 equivalent of CuI with the addition of TMSCl (Table 1, entry 5). Similar enhancement of reactivity was observed with 0.3 equivalent of CuCN in the presence of TMSCl (Table 1, entry 6). With the addition of TMSCl, lithium cyanocuprate reagent underwent smooth conjugate addition to thiochromone 3A to afford 2-alkylthiochroman-4-one 4Aa with 70% yield (Table 1, entry 7). Ultimately, lithium dialkylcuprate (i.e., n-Bu2CuLi) was found to be the most reactive and it afforded the highest yield of 1,4-adduct 4Aa at 86% with the addition of TMSCl (Table 1, entry 8). The effect of other Lewis acid additives, such as TMSI and TMSOTf, were also investigated. Both TMSI and TMSOTf showed similar enhancement and promoted the conjugate addition of lithium di-n-butylcuprates to thiochroman-4-one with good yields (Table 1, entries 9–10, 85% and 82%). With the optimal reaction condition in hand, we examined the scope of lithium dialkylcuprates (i.e., R2CuLi) (Scheme 2, 60–86%). In general, a number of lithium dialkylcuprates underwent conjugate addition to thiochromone 3A to afford 1,4-adducts 4Aa-Am with good chemical yields (Scheme 2). Simple dialkylcuprates, such as dimethylcuprates, diethyl cuprate, di-n-butylcuprates, and di-n-hexylcuprates all add to 3A smoothly to afford 1,4-adducts with good yields (Scheme 2, 81–86%). Lithium di-isopropylcuprate and di-t-buylcuprates also add to thiochromone 3A with slightly lower yields (Scheme 2, 71% and 60%), indicating that organocuprates that are prepared from more hindered alkyllithium reagents are less reactive.
Scheme 2

The Scope of Lithium Dialkylcuprates in Conjugate Addition to Thiochromone. a. All the reactions were performed using 1.2 equivalentof R2CuLi in the presence of 2.0 equivalent of TMSCl unless noted otherwise. b. RLi were commercially available. c. Yields are based on isolated products by flash column chromatography. d. Reactions were stirred for 12 h and warm up to room temperature before work up.

Having found the optimal reaction condition for conjugate addition to thiochromone 3A, we next turned our attention to explore the scope of thiochromone substrates for the lithium dialkylcuprate conjugate addition. A number of substituted thiochromones 3B-J were investigated. It was found that lithium di-n-butylcuprates (i.e., n-Bu2CuLi) readily add to substituted thiochromones 3B-J to afford 1,4-adducts 4Ba-Ja with 74–85% yields (Scheme 3). Thiochromones bearing simple substituents, such as methyl group, reacted with n-Bu2CuLi to afford 4Ba-Da in 81–84% yields (Scheme 3). Bulky t-butyl group is also tolerated to afford 1,4-adduct 4Ea with good yield. Thiochromones with halides F, Br, and Cl also work well with lithium di-n-butylcuprates (Scheme 3, 79–85%). Thiochromones with electron-donating groups, such as MeO-, also work well to afford 1,4-adduct 4Ia in 76% yield (Scheme 3). Thiochromane 3J with extended aromatic structure also undergo conjugate addition with n-Bu2CuLi to afford 1,4-adduct 4Ja in 74% yield.
Scheme 3

Reactions of Lithium di-n-butylcuprates with Substitututed Thiochromones. a. All the reactions were performed using 1.2 equivalentof n-Bu2CuLi in the presence of 2.0 equivalent of TMSCl unless noted otherwise. b. n-BuLi is commercially available. c. Yields are based on isolated products by flash column chromatography. d. Reactions were stirred for 12 h and warm up to room temperature before work up.

Synthetic applications of 1,4-adducts: The 1,4-adducts-2-alkylthiochroman-4-ones can be utilized for additional synthetic applications (Scheme 4). For example, 2-n-butylthiochroman-4-one can be reduced to corresponding alcohol 5 by treatment with sodium borohydride in ethanol. Upon treatment with N-chlorosuccinimide (NCS) in dichloromethane, thiochroman-4-one 4Aa was successfully converted into thiochromone 6 in 71% yield. 2-n-Butylthiochroman-4-one 4Aa can be oxidized to sulfone 7 with an excess of m-chloroperbenzoic acid (m-CPBA) in dichloromethane (Scheme 4, 79%). It can also be functionalized to chlorinated thiochromone 8 upon treatment with excess of N-chlorosuccinimide (NCS, 3.0 equivalent) and pyridine (3.0 equivalent) (Scheme 4, 62%).
Scheme 4

Synthetic Applications of 2-n-butyl Thiochroman-4-one.

3. Materials and Methods

3.1. General Methods

The 1H, 13C, and 19F-NMR spectra were recorded on a BRUKER AscendTM 400 NMR spectrometer (Billerica, MA, USA), operating at 400 MHz for 1H and 100 MHz for 13C and 376 MHz for 19F. Samples for NMR spectra were dissolved in deuterated chloroform (with TMS). Analytical thin layer chromatography (TLC) was performed on silica gel plates, 60 µ mesh with F254 indicator. Visualization was accomplished by UV light (254 nm), and/or a 10% ethanol solution of phosphomolybdic acid and/or KMnO4 stain that is prepared by dissolving 1.5 g KMnO4, 10 g potassium carbonate, and 1.25 mL 10% sodium hydroxide in 200 mL water. Flash chromatography was performed with 230–400 µ silica gel. Infrared (IR) spectra were recorded on a Nicolet iS10 FT-IR spectrometer as neat samples (thin films).

3.2. Materials

Solvents and chemicals were obtained from commercial sources and used without further purification unless stated otherwise. Anhydrous tetrahydrofuran (THF) was purchased from Sigma Aldrich (Milwaukee, WI, USA). TMSCl was distilled from CaH2 under a positive N2 atmosphere. Alkyllithium reagents were purchased from Sigma Aldrich. All of the glassware was flamed-dried under high vacuum, purged with argon, and then cooled under a dry nitrogen atmosphere. Low temperature baths were prepared using dry ice-isopropanol slush bath mixtures. All organocuprate 1,4-conjugate addition reactions were conducted under a positive, dry argon atmosphere in anhydrous solvents in flasks that were fitted with a rubber septum.

3.3. General Procedure A: Conjugate Addition Reactions of Lithium Alkylcyanocuprates (RCuCNLi) with Thiochromones

To a flame-dried LiCl (51 mg, 1.2 mmol, 2.4 equivalent) under argon was added CuCN (53 mg, 0.6 mmol, 1.2 equivalent) and THF (1.5 mL). The resultant mixture was stirred for 10 mins at room temperature and then cooled to a −78 °C, followed by addition of alkyl lithium (0.6 mmol, 1.2 equivalent). The resultant solution was stirred for additional 30 mins at −78 °C under argon, followed by addition of thiochromone (0.5 mmol mixed with TMSCl (1.0 mmol) in THF (1.0 mL)) at −78 °C. The reaction mixture was allowed to warm up to room temperature during overnight stirring. Then, the reaction mixture was quenched with saturated aqueous NH4Cl (ca. 10.0 mL) and extracted with ethyl acetate (3 × 10.0 mL). The combined organic phase was washed with brine (ca. 15.0 mL), dried over anhydrous Na2SO4, filtered, concentrated in vacuo, and purified by flash column chromatography (silica gel, 0–2% ethyl acetate in hexane, v/v) to give pure compounds.

3.4. General Procedure B: Conjugate Addition Reactions of Lithium Dialkylcuprates (R2CuLi) with Thiochromones

General procedure B is identical to general procedure A except that double amount of alkyl lithium reagents (1.2 mmol, 2.4 equivalent) were used.

3.5. General Procedure C: Conjugate Addition Reactions of Alkyl Lithium Reagents with Thiochromone in the Presence of Substoichiometric Amount of CuI

To a CuI (0.30 equivalent) in THF (1.0 mL) under argon at 0 °C, was added alkyl lithium (1.2 equivalent). The resultant mixture was stirred for 30 min at room temperature 0 °C and then cooled to a −78 °C, followed by addition of thiochromone [0.5 mmol mixed with TMSCl (1.0 mmol) in THF (1.0 mL)]. The reaction mixture was allowed to warm up to room temperature during overnight stirring. Then, the reaction mixture was quenched with saturated aqueous NH4Cl (ca. 10.0 mL) and extracted with ethyl acetate (3 × 8.0 mL). The combined organic phase was washed with brine (ca. 10.0 mL), dried over anhydrous Na2SO4, filtered, concentrated in vacuo, and purified by flash column chromatography (silica gel, 0–2% ethyl acetate in hexane, v/v) to give pure compounds. HRMS data for compounds 4Aa, 4Ba4Ja, 5, 7, and 8 were analyzed by TOF MS. Compounds 4Ab–Ac, 4Ad–Af, and 6 have been fully characterized and reported [39,43,48,67].

3.5.1. Synthesis of 2-n-Butylthiochroman-4-one (4Aa)

Employing General Procedure B, using n-BuLi (2.8 M, 0.43 mL, 1.2 mmol) and thiochromone (81 mg, 0.5 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Aa (95 mg, 86%). Alternatively, 2-n-butylthiochroman-4-one (4Aa) was prepared by employing General Procedure A, using n-BuLi (2.8 M, 0.22 mL, 0.6 mmol) and thiochromone (81 mg, 0.5 mmol), after purification by flash column chromatography (silica, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Aa (77 mg, 70%); 2-n-butylthiochroman-4-one (4Aa) was also prepared by employing General Procedure C, using n-BuLi (2.8 M, 0.22 mL, 0.6 mmol), CuI (29 mg) and thiochromone (81 mg, 0.5 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Aa (72 mg, 66%): IR (neat) 3058 (w), 2955 (s), 2927 (s), 2857 (s), 1676 (s), 1588 (s), 1457 (m), 1435 (s), 1286 (s), 1231 (w), 1088 (m), 758 (m) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.94 (t, J = 7.2 Hz, 3H), 1.31–1.41 (m, 2H), 1.46 (quintet, J = 7.6 Hz, 2H), 1.74 (q, J = 7.6 Hz, 2H), 2.82 (dd, J = 11.2, 16.4 Hz, 1H), 3.07 (dd, J = 3.2, 16.4 Hz, 1H), 3.46–3.55 (m, 1H), 7.14–7.21 (m, 1H), 7.28 (d, J = 8.0 Hz, 1H), 7.37–7.43 (m, 1H), 7.14 (ddd, J = 0.4, 0.8, 8.0 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.3, 28.8, 34.2, 41.6, 46.3, 124.9, 127.6, 128.9, 130.7, 133.4, 141.7, 194.8; HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H16OS, 220.0922; found 220.0918.

3.5.2. Synthesis of 6-Methyl-2-n-butylthiochroman-4-one (4Ba)

Employing General Procedure B and using 6-methylthiochromone (176 mg, 1.00 mmol) and n-BuLi (2.8 M, 0.86 mL, 2.40 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Ba (190 mg, 81%); IR (neat) 3046 (w), 2955 (s), 2924 (s), 2856 (s), 1675 (s), 1602 (m), 1468 (m), 1398 (m), 1299 (w), 1278 (m), 1231 (w), 1097 (w), 814 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.70 (t, J = 7.2 Hz, 3H), 1.03–1.14 (m, 2H), 1.17–1.30 (m, 2H), 1.50 (q, J = 7.6 Hz, 2H), 2.11 (s, 3H), 2.57 (dd, J = 11.2, 16.4 Hz, 1H), 2.82 (dd, J = 2.8, 16.4 Hz, 1H), 3.21–3.30 (m, 2H), 6.95 (d, J = 8.0 Hz, 1H), 7.00 (ddd, J = 0.4, 2.0, 8.4 Hz, 1H), 7.67–7.70 (m, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 20.8, 22.3, 28.9, 34.2, 41.7, 46.5, 127.6, 129.0, 130.5, 134.6, 134.7, 138.3, 195.1; HRMS (EI-ion trap) m/z: [M]+ calcd. for C14H18OS, 234.1078; found 234.1082.

3.5.3. Synthesis of 6,7-Dimethyl-2-n-butylthiochroman-4-one (4Ca)

Employing General Procedure B and using 6,7-dimethylthiochromone (190 mg, 1.00 mmol) and and n-BuLi (2.8 M, 0.86 mL, 2.40 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow solid 4Ca (208 mg, 84%): m.p. 64.0–64.9 °C; IR (neat) 2956 (s) 2920 (s), 2860 (s), 1669 (s), 1599 (s), 1470 (m), 1447 (m), 1383 (m), 1370 (m), 1262 (s), 1147 (m), 1100 (m), 1023 (w), 864 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.84 (t, J = 7.2 Hz, 3H), 1.21–1.31 (m, 2H), 1.36 (dt, J = 5.2, 7.6 Hz, 2H), 1.63 (q, J = 7.6 Hz, 2H), 2.16 (s, 3H), 2.17 (s, 3H), 2.68 (dd, J = 11.2, 16.4 Hz, 1H), 2.93 (dd, J = 3.2, 16.4 Hz, 1H), 3.30–3.43 (m, 1H), 7.14–7.21 (m, 1H), 7.28 (d, J = 8.0 Hz, 1H), 7.37–7.43 (m, 1H), 6.97 (s, 1H), 7.77 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 19.2, 20.0, 22.3, 28.9, 34.2, 41.8, 46.4, 128.4, 128.6, 129.5, 133.8, 138.6, 143.7, 194.8; HRMS (EI-ion trap) m/z: [M]+ calcd. for C15H20OS, 248.1235; found 248.1236.

3.5.4. Synthesis of 8-Methyl-2-n-butylthiochroman-4-one (4Da)

Employing General Procedure B and using 8-methylthiochromone (176 mg, 1.0 mmol) and n-BuLi (2.8 M, 0.43 mL, 1.2 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Da (194 mg, 83%); IR (neat) 3061 (w), 2955 (m) 2926 (s), 2857 (m), 1676 (s), 1583 (m), 1449 (m), 1401 (m), 1379 (w), 1295 (m), 1279 (m), 1248 (w), 1056 (w), 1000 (w), 841 (w) 784 (w), 722 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.73 (t, J = 7.2 Hz, 3H), 1.11–1.21 (m, 2H), 1.22–1.35 (m, 2H), 1.51–1.60 (m, 2H), 2.12 (s, 3H), 2.58 (dd, J = 11.6, 16.0 Hz, 1H), 2.83 (dd, J = 2.8, 16.0 Hz, 1H), 3.21–3.29 (m, 1H), 6.88 (t, J = 7.6 Hz, 1H), 7.09 (qd, J = 0.8, 8.0 Hz, 1H), 7.78 (qd, J = 0.4, 8.0 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 20.1, 22.4, 28.8, 34.4, 40.7, 45.7, 123.9, 126.6, 130.8, 134.5, 135.4, 141.3, 195.2; HRMS (EI-ion trap) m/z: [M]+ calcd. for C14H18OS, 234.1078; found 234.1075.

3.5.5. Synthesis of 6-(tert-Butyl)-2-n-butylthiochroman-4-one (4Ea)

Employing General Procedure B and using 6-tert-butylthiochromone (86 mg, 0.42 mmol) and and n-BuLi (2.8 M, 0.36 mL, 1.01 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Ea (89 mg, 77%); IR (neat) 3054 (w), 2955 (s), 2928 (s), 2869 (m), 1678 (s), 1596 (m), 1479 (m), 1463 (m), 1463 (m), 1252 (s), 1119 (m), 824 (m) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.84 (t, J = 7.2 Hz, 3H), 1.24 (s, 9H), 1.21–1.30 (m, 2H), 1.32–1.46 (m, 2H), 1.64 (q, J = 7.6 Hz, 2H), 2.72 (dd, J = 11.2, 16.4 Hz, 1H), 2.97 (dd, J = 3.2, 16.4 Hz, 1H), 3.35–3.45 (m, 1H), 7.13 (d, J = 8.40 Hz, 1H), 7.37 (dd, J = 2.4, 8.4 Hz, 1H), 8.04 (d, J = 2.40 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.3, 28.9, 31.1, 34.3, 34.6, 41.6, 46.5, 125.4, 127.4, 130.2, 131.2, 138.5, 148.1, 195.2; HRMS (EI-ion trap) m/z: [M]+ calcd. for C17H24OS, 276.1548; found 276.1544.

3.5.6. Synthesis of 6-Chloro-2-n-butylthiochroman-4-one (4Fa)

Employing General Procedure B, and using 6-chlorothiochromone (130 mg, 0.66 mmol) and n-BuLi (2.8 M, 0.57 mL, 1.58 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Ea (143 mg, 85%); IR (neat) 3057 (w), 2955 (s), 2927 (s), 2857 (m), 1682 (s), 1582 (m), 1452 (s), 1391 (m), 1293 (w), 1253 (m), 1224 (w), 1157 (w), 1094 (m), 898 (w), 815 (w), 730 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.94 (t, J = 7.2 Hz, 3H), 1.32–1.40 (m, 2H), 1.41–1.50 (m, 2H), 1.74 (q, J = 7.6 Hz, 2H), 2.81 (dd, J = 11.2, 16.4 Hz, 1H), 3.06 (dd, J = 3.2, 16.4 Hz, 1H), 3.45–3.54 (m, 1H), 7.23 (d, J = 8.4 Hz, 1H), 7.36 (dd, J = 2.4, 8.4 Hz, 1H), 8.06 (d, J = 2.4 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.3, 28.8, 34.1, 41.7, 45.9, 128.5, 129.1, 131.1, 131.6, 133.4, 140.1, 193.6; HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H15OSCl, 254.0532; found 254.0534.

3.5.7. Synthesis of 6-Bromo-2-n-butylthiochroman-4-one (4Ga)

Employing General Procedure B and using 6-bromothiochromone (130 mg, 0.54 mmol) and n-BuLi (2.8 M, 0.39 mL, 1.08 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Ga (132 mg, 82%); IR (neat) 3054 (w), 2955 (m) 2926 (s), 2856 (m), 1679 (s), 1574 (m), 1474 (m), 1450 (m), 1386 (m), 1291 (w), 1254 (m), 1224 (w), 1091 (m), 1054 (w), 898 (w), 813 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.84 (t, J = 7.2 Hz, 3H), 1.21–1.31 (m, 2H), 1.32–1.41 (m, 2H), 1.64 (q, J = 7.6 Hz, 2H), 2.71 (dd, J = 11.2, 16.4 Hz, 1H), 2.97 (dd, J = 2.8, 16.4 Hz, 1H), 3.36–3.45 (m, 1H), 7.07 (d, J = 8.4 Hz, 1H), 7.40 (dd, J = 2.0, 8.4 Hz, 1H), 8.12 (d, J = 2.4 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.3, 28.8, 34.1, 41.7, 45.8, 118.6, 129.3, 131.5, 131.9, 136.2, 140.7, 193.5; HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H15OSBr, 298.0027; found 298.0033.

3.5.8. Synthesis of 6-Fluoro-2-n-butylthiochroman-4-one (4Ha)

Employing General Procedure B and using 6-fluorothiochromone (100 mg, 0.56 mmol) and n-BuLi (2.8 M, 0.48 mL, 1.34 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Ha (105 mg, 79%); IR (neat) 3066 (w), 2957 (m) 2928 (s), 2858 (m), 1682 (s), 1601 (m), 1464 (s), 1404 (s), 1303 (m), 1262 (s), 1223 (w), 1196 (w), 1089 (w), 895 (w), 817 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.94 (t, J = 7.2 Hz, 3H), 1.32–1.41 (m, 2H), 1.42–1.50 (m, 2H), 1.74 (q, J = 7.6 Hz, 2H), 2.81 (dd, J = 11.2, 16.4 Hz, 1H), 3.07 (dd, J = 2.8, 16.4 Hz, 1H), 3.46–3.55 (m, 1H), 7.15 (ddd, J = 2.8, 8.0, 8.4 Hz, 1H), 7.27 (dd, J = 5.2, 8.8 Hz, 1H), 7.79 (dd, J = 3.2, 9.6 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.3, 28.8, 34.0, 41.8, 46.0, 114.9 (d, J = 22 Hz), 121.4 (d, J = 22 Hz), 129.4 (d, J = 7 Hz), 132.0 (d, J = 6 Hz), 136.9 (d, J = 3 Hz), 160.4 (d, J = 244 Hz), 193.8; 19F NMR (376 MHz, CDCl3) δ - 116.8 (quintet, J = 3.76 Hz); HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H15OSF, 238.0828; found 238.0827.

3.5.9. Synthesis of 6-Methoxy-2-n-butylthiochroman-4-one (4Ia)

Employing General Procedure B and using 6-methoxydimethylthiochromone (76 mg, 0.4 mmol) and and n-BuLi (2.8 M, 0.34 mL, 0.96 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oil 4Ia (76 mg, 76%); IR (neat) 3065 (w), 2955 (m) 2925 (s), 2854 (m), 1675 (s), 1599 (m), 1471 (s), 1403 (m), 1323 (w), 1273 (s), 1222 (s), 1180 (w), 1099 (w), 1027 (m), 870 (w), 820 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.84 (t, J = 7.2 Hz, 3H), 1.21–1.31 (m, 2H), 1.39 (td, J = 2.0, 14.8 Hz, 2H), 1.64 (q, J = 7.6 Hz, 2H), 2.71 (dd, J = 11.2, 16.4 Hz, 1H), 2.97 (dd, J = 2.8, 16.4 Hz, 1H), 3.30–3.49 (m, 1H), 3.75 (s, 3H), 6.94 (dd, J = 2.8, 8.8 Hz, 1H), 7.11 (dd, J = 0.4, 8.8 Hz, 1H), 7.52 (d, J = 2.8 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.3, 28.9, 34.1, 41.9, 46.5, 55.6, 111.0, 122.5, 129.0, 131.4, 133.1, 157.3, 194.8; HRMS (EI-ion trap) m/z: [M]+ calcd. for C14H18O2S, 250.1028; found 250.1029.

3.5.10. Synthesis of 2-n-Butyl-2,3-dihydro-4H-benzo[g]thiochromen-4-one (4Ja)

Employing General Procedure B and using 6,7-dimethylthiochromone (106 mg, 0.5 mmol) and and n-BuLi (2.8 M, 0.43 mL, 1.2 mmol), after purification by flash column chromatography (silica gel, 0–2% ethyl acetate:hexanes, v/v) gave light yellow oily liquid 4Ja (100 mg, 74%); IR (neat) 3051 (w), 2954 (s) 2926 (s), 2856 (m), 1660 (s), 1613 (m), 1590 (m), 1549 (w), 1504 (m), 1464 (w), 1422 (m), 1335 (m), 1215 (m), 1111 (m), 872 (w), 813 (m), 779 (w), 746 (m) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.86 (t, J = 7.2 Hz, 3H), 1.25–1.35 (m, 2H), 1.36–1.46 (m, 2H), 1.70 (q, J = 7.6 Hz, 2H), 2.87 (dd, J = 11.2, 15.2 Hz, 1H), 3.09 (dd, J = 3.6, 15.2 Hz, 1H), 3.45–3.54 (m, 1H), 7.19 (d, J = 8.4 Hz, 1H), 7.34–7.40 (m, 1H), 7.52 (ddd, J = 1.6, 6.8, 8.8 Hz, 1H), 7.64–7.68 (m, 1H), 7.71 (d, J = 8.8 Hz, 1H), 9.12 (dd, J = 0.8, 8.8 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.9, 22.4, 28.8, 34.2, 41.3, 47.7, 125.1, 125.4, 125.6, 125.8, 128.4, 129.2, 131.7, 132.3, 133.7, 144.7, 197.0; HRMS (EI-ion trap) m/z: [M]+ calcd. for C17H18OS, 270.1078; found 270.1074.

3.6. Synthesis of 2-n-Buylthiochroman-4-ol (

To a dry ethanol solution (1.5 mL) of 2-n-butylthiochroman-4-one (0.5 mmol, 110 mg) under argon, sodium borohydride (0.25 mmol, 10 mg) was added portion-wise. The resultant mixture was stirred at room temperature for 2 h. Then solvent was evaporated, ice water (10 mL) was added, and the mixture was acidified with 10% HCl to pH = 1–2. It was then extracted with ethyl acetate (3 × 8 mL) and organic layers were combined, washed with brine (15 mL). The organic layer was dried (Na2SO4), filtered and evaporated under vacuum to give crude product. The crude product was then purified by flash column chromatography (silica gel, 10% ethyl acetate:hexanes, v/v) to give 2-n-butylthiochroman-4-ol 5 as white solid (91 mg, 82%): m.p. 64.1–65.2 °C; IR (neat) 3317 (br s), 3065 (w), 2958 (s), 2924 (s), 2855 (s), 1591 (w), 1566 (w), 1466 (m), 1433 (s), 1349 (w), 1308 (m), 1263 (m), 1196 (w), 1059 (m), 1034 (m), 1016 (m), 978 (w), 759 (m), 750 (s), 730 (m), 688 (w) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.96 (t, J = 7.2 Hz, 3H), 1.36–1.50 (m, 3H), 1.60–1.75 (m, 2H), 1.75–1.86 (m, 1H), 2.27 (d, J = 8 Hz, 1H), 2.46 (ddd, J = 3.2, 4.4, 12.8 Hz, 1H), 3.38–3.48 (m, 1H), 7.07–7.16 (m, 3H), 7.53–7.59 (m, 1H); 13C-NMR (100 MHz, CDCl3) δ 14.0, 22.5, 28.9, 36.3, 40.0, 40.3, 69.2, 124.4, 126.1, 126.2, 127.6, 133.3, 137.1; HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H18OS, 222.1078; found 222.1084.

3.7. Synthesis of 2-n-Butyl-thiochromen-4-one 1,1-dioxide (

To a dry DCM (dichloromethane) solution of 2-n-butylthiochroman-4-one (0.5 mmol) under Ar atmosphere in a 50 mL RB (round-bottom) flask, was added excess 3-meta-chloroperoxybenzoic acid (m-CPBA, 3.0 equivalent, 1.5 mmol, 259 mg). The resultant mixture was stirred at room temperature until the reaction is complete by TLC monitoring (5 h). Then the reaction mixture was quenched with NaHCO3 (10 mL) and diluted with DCM (8 mL). The organic layer were separated and aqueous layer was extracted with DCM (2 X 8 mL). The organic layers were combined and washed with brine and dried over anhydrous Na2SO4. It was filtered and concentrated in vacuum. The crude product was purified by flash column chromatography (silica gel, 20% ethyl acetate:hexanes, v/v) to give transparent/clear yellow liquid 7 (100 mg, 79%): IR (neat) 3067 (w), 2956 (s), 2930 (s), 2869 (m), 1691 (s), 1588 (m), 1571 (w), 1466 (w), 1443 (w), 1300 (s), 1279 (s), 1231 (m), 1150 (s), 1125 (m), 1045 (w), 936 (w), 751 (m), 722 (m) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.96 (t, J = 7.2 Hz, 3H), 1.35–1.43 (m, 2H), 1.46–1.59 (m, 2H), 1.61–1.72 (m, 2H), 2.22–2.33 (m, 1H), 3.28 (dd, J = 10, 17.6 Hz, 1H), 3.39 (dd, J = 3.6, 17.6 Hz, 1H), 3.58–3.67 (m, 1H), 7.76 (td, J = 1.2, 7.6 Hz, 1H), 7.85 (td, J = 1.2, 7.6 Hz, 1H), 8.07 (dd, J = 0.8, 7.6 Hz, 1H), 8.13 (dd, J = 0.8, 7.6 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.7, 22.3, 25.8, 28.2, 42.0, 59.1, 124.2, 128.5, 130.5, 133.2, 135.0, 141.1, 190.7; HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H16O3S, 252.0820; found 252.0823.

3.8. Synthesis of 3-Chloro-2-n-butyl-4H-thiochromen-4-one (

To a DCM solution of 2-n-butylthiochroman-4-one (1.0 equivalent, 0.5 mmol) was added NCS (N-chlorosuccinimide) (3.0 equivalent, 1.5 mmol, 200 mg) and pyridine (3.0 equivalent, 1.5 mmol, 119). The reaction mixture was stirred at room temperature for 3 h and then concentrated under vacuum to give the crude product, which was purified by flash column chromatography (silica gel, 5% ethyl acetate:hexanes, v/v) to give 8 as a white solid (78 mg, 62%): m.p. 40.5–41.3 °C; IR (neat) 3062 (w), 2959 (m), 2928 (m), 2858 (m), 1622 (s), 1567 (s), 1585 (m), 1532 (s), 1464 (m), 1437 (m), 1321 (m), 1254 (w), 1156 (w), 1098 (m), 1070 (w), 834 (m), 739 (m) cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.92 (t, J = 7.2 Hz, 3H), 1.41 (sextet, J = 7.2 Hz, 2H), 1.65–1.74 (m, 2H), 2.80–2.86 (m, 2H), 7.45–7.59 (m, 3H), 8.48 (ddd, J = 0.8, 1.6, 8.0 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.7, 22.5, 30.7, 36.4, 125.6, 126.5, 127.8, 129.6, 130.4, 131.5, 135.8, 150.9, 174.3; HRMS (EI-ion trap) m/z: [M]+ calcd. for C13H13OSCl, 252.0376; found 252.0381.

4. Conclusions

In conclusion, we have successfully developed the conjugate addition of lithium dialkylcuprates to thiochromones in the presence of chlorotrimethylsilane (TMSCl) and other Lewis acids, such as TMSI and TMSOTf, to afford 2-alkylthiochroman-4-ones in good yields utilizing commercially available inexpensive alkyllithium reagents. This reaction works well with simple dialkylcuprates as well as bulky dialkylcuprates (i-Pr2CuLi, t-Bu2CuLi). Lithium di-n-butylcuprate undergoes smooth conjugate addition to a broad range of substituted thiochromones. The 1,4-adducts (2-alkylthiochroman-4-ones) can be utilized for additional synthetic applications to access privileged sulfur-heterocycles. Further synthetic applications using these 1,4-adducts as key intermediates are ongoing in our lab.
  45 in total

1.  Inhibition of cdk1 by alsterpaullone and thioflavopiridol correlates with increased transit time from mid G2 through prophase.

Authors:  Deena V Soni; James W Jacobberger
Journal:  Cell Cycle       Date:  2004-03-01       Impact factor: 4.534

2.  A practical access to highly enantiomerically pure flavanones by catalytic asymmetric transfer hydrogenation.

Authors:  Marie-Kristin Lemke; Pia Schwab; Petra Fischer; Sandra Tischer; Morris Witt; Laurence Noehringer; Victor Rogachev; Anne Jäger; Olga Kataeva; Roland Fröhlich; Peter Metz
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-11       Impact factor: 15.336

3.  Cascade Michael--aldol reactions promoted by hydrogen bonding mediated catalysis.

Authors:  Liansuo Zu; Jian Wang; Hao Li; Hexin Xie; Wei Jiang; Wei Wang
Journal:  J Am Chem Soc       Date:  2007-02-07       Impact factor: 15.419

4.  Two-Component Assembly of Thiochroman-4-ones and Tetrahydrothiopyran-4-ones Using a Rhodium-Catalyzed Alkyne Hydroacylation/Thio-Conjugate-Addition Sequence.

Authors:  Anaïs Bouisseau; John Glancy; Michael C Willis
Journal:  Org Lett       Date:  2016-10-25       Impact factor: 6.005

5.  Encoding social signals in the mouse main olfactory bulb.

Authors:  Da Yu Lin; Shao-Zhong Zhang; Eric Block; Lawrence C Katz
Journal:  Nature       Date:  2005-02-20       Impact factor: 49.962

6.  Microwave-assisted three-component coupling-addition-S(N)Ar (CASNAR) sequences to annelated 4H-thiopyran-4-ones.

Authors:  Benjamin Willy; Walter Frank; Thomas J J Müller
Journal:  Org Biomol Chem       Date:  2009-10-23       Impact factor: 3.876

7.  Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.

Authors:  H K Wang; K F Bastow; L M Cosentino; K H Lee
Journal:  J Med Chem       Date:  1996-05-10       Impact factor: 7.446

8.  Stannous chloride-mediated reductive cyclization-rearrangement of nitroarenyl ketones.

Authors:  Dallas K Bates; Kexue Li
Journal:  J Org Chem       Date:  2002-11-29       Impact factor: 4.354

9.  2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.

Authors:  Peter Nussbaumer; Philipp Lehr; Andreas Billich
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

10.  Asymmetric synthesis of tertiary thiols and thioethers.

Authors:  Jonathan Clayden; Paul Maclellan
Journal:  Beilstein J Org Chem       Date:  2011-05-10       Impact factor: 2.883

View more
  1 in total

1.  Conjugate Addition of Grignard Reagents to Thiochromones Catalyzed by Copper Salts: A Unified Approach to Both 2-Alkylthiochroman-4-One and Thioflavanone.

Authors:  Tania J Bellinger; Teavian Harvin; Ti'Bran Pickens-Flynn; Nataleigh Austin; Samuel H Whitaker; Mai Ling C Tang Yuk Tutein; Dabria T Hukins; Nichele Deese; Fenghai Guo
Journal:  Molecules       Date:  2020-05-01       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.